BG Medicine's Heart Test Powers 175 Percent Revenue Growth in Q4 | GenomeWeb

NEW YORK (GenomeWeb News) – BG Medicine today reported a 175 percent increase year over year in revenues for the fourth quarter as product revenues increased more than three-fold.

The Waltham, Mass.-based firm said that revenues for the three months ended Dec. 31, 2012 totaled $1.1 million, up from $379,000 a year ago and beating the average analyst estimate of $940,000. Product revenues increased to $978,000 from $307,000 a year ago, and service revenues rose to $94,000 from $72,000, a 31 percent jump.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.